OBServaToire INternational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.
Eligibility
Participation Requirements
Sex: All
View:
• Patient receiving a comprehensive information about the study, and not opposed to participate
• Age ≥ 18 yo
• Classification of definite APS according to revised Sapporo-Sydney criteria
• Direct oral anticoagulant treatment prescribed during at least 6 months or with the possibility of follow-up of at least 6 months
Locations
Other Locations
France
Stéphane Zuily
RECRUITING
Nancy
Contact Information
Primary
Virginie Dufrost, MD, MSc
v.dufrost@chru-nancy.Fr
+33383157828
Time Frame
Start Date: 2020-10-21
Estimated Completion Date: 2030-04
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Collaborators: International Society on Thrombosis and Haemostasis
Leads: Stéphane Zuily